Abstract

Background: Medicines are essential part of any healthcare system. Limited access to medicines undermine in healthcare systems. Ethiopian Food, Medicine and Healthcare Administration and Control Authority had been mandated to ensure quality, safety and efficacy of medicines nonetheless medicines registration process contributes to the availability of quality and safe medicine in Ethiopia. 80% of medicines used in Ethiopia were imported from abroad; in this regard, medicines registration process should be effective and avoid unnecessary delays in Ethiopia.

Objective: The main aim of this study was to explore the challenges of medicines registration process in Ethiopia.

Methods: Qualitative phenomenological study design was employed. Purposive sampling technique was used to select study participants until saturation point of themes reached. Key informant interviews and focus group discussion were used to collect data using unstructured questionnaires. The data were analyzed by thematic content analysis technique.

Results: In the present study different challenges were identified and explored; among these challenges: limitation on Ethiopian medicine registration guideline; inadequate human resources and prolonged medicine registration process. Hence, it results delayed the medicine registration process. Another challenge were dossier related challenges such as most local manufactures and medicines importers were lack of skilled about common technical documents required for medicine dossier submission and which is the most challenge identified for medicine registration process in Ethiopia.

Conclusion: In this study various challenges for medicine registration process were identified and explored. Hence, the Ethiopia Food, Medicine and Healthcare Administration and Control Authority should developed strategy for effective medicine registration process.

Keywords: Challenges; EFMHACA; Guideline; Medicines Registration

References

1. Ethiopia Food, Medicine and Health Care Administration and Control Proclamation (2010).
2. Lambert J. “Ethiopia: Traditional medicine and the bridge to better health”. IK Notes (2001): 35.
3. Narsai K., et al. “Impact of regulatory requirements on medicine registration in African countries–perceptions and experiences of pharmaceutical companies in South Africa”. Southern Med Review 5 (2012): 31.
4. Ethiopia Food, Medicine and Healthcare and administration and control Authorty: Expediting Medicine Market Authorization Strategy (2017).
5. National strategy and plan of action for pharmaceutical manufacturing development in Ethiopia 2015.
6. Sahoo N., et al. “Herbal drugs: standards and regulation”. Fitoterapia 81 (2010): 462-471.
7. Ngcobo M., et al. “Recommendations for the development of regulatory guidelines for registration of traditional medicines in South Africa”. African Journal of Traditional, Complementary and Alternative Medicines 9 (2012): 59-66.
8. Kassaye KD., et al. “A historical overview of traditional medicine practices and policy in Ethiopia”. Ethiopian Journal of Health Development 2 (2006): 127-134.
9. “Regulatory harmonization: updating medicines regulatory systems in sub-Saharan African countries”. WHO Drug Information 24 (2010): 6-20.
10. Sterckx S. “Patents and access to drugs in developing countries: an ethical analysis”. Developing World Bioethics 4 (2004): 58-75.
11. Moran M., et al. “Registering new drugs for low-income countries: the African challenge”. PLoS medicine 8 (2011): e1000411.
12. Dong J and Mirza Z. “Supporting the production of pharmaceuticals in Africa”. Bulletin of the World Health Organization1 (2016): 71.
13. Hill S and Johnson K. Emerging challenges and opportunities in drug registration and regulation in developing countries: Department for International Development (2004).
14. Mkumbwa SH. Challenges of medicines registration process in Tanzania: Muhimbili University of Health and Allied Sciences (2013).
15. Bate R., et al. “Medicine registration and medicine quality: a preliminary analysis of key cities in emerging markets” (2010).
16. “Drug Regulation in Kenya”. News Letter 2 (2014).
17. Barkan ID. “Industry invites regulation: the passage of the Pure Food and Drug Act of 1906”. American Journal of Public Health 75 (1985): 18-26.
18. Garattini S. “Adjusting Europe's drug regulation to public health needs”. The Lancet 358 (2001): 64-67.
19. Homedes N and Ugalde A. “Multisource drug policies in Latin America: survey of 10 countries”. Bulletin of the World Health Organization 83 (2005): 64-70.
20. Suleman S., et al. “Pharmaceutical regulatory framework in Ethiopia: a critical evaluation of its legal basis and implementation”. Ethiopian Journal of Health Sciences3 (2016): 259-276.
21. Bishaw M. “Promoting traditional medicine in Ethiopia: a brief historical review of government policy”. Social Science and Medicine 33 (1991): 193-200.
22. Proceeding of the Workshop on Ethiopian Traditional Medicine: Past, Current and Future (2015).
23. Zaidi S., et al. “Access to essential medicines in Pakistan: policy and health systems research concerns”. PloS One 8 (2013): e63515.
24. Citizen Charter of Ethiopian Food, Medicine and healthcare Administrational control Authority. (2008).
25. Guideline for Registration of Medicines in Ethiopia, third Edition (2014).

Citation

Citation: DebalkeFantaw and Belayneh Kefale. "Explore the Challenge in Medicines Registration Process in Ethiopia: Qualitative Phenomenological Study". Acta Scientific Pharmaceutical Sciences 4.1 (2020): 44-51.